0001493152-20-003175.txt : 20200302
0001493152-20-003175.hdr.sgml : 20200302
20200228181041
ACCESSION NUMBER: 0001493152-20-003175
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200302
DATE AS OF CHANGE: 20200228
EFFECTIVENESS DATE: 20200302
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aeterna Zentaris Inc.
CENTRAL INDEX KEY: 0001113423
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-361690
FILM NUMBER: 20673101
BUSINESS ADDRESS:
STREET 1: C/O STIKEMAN ELLIOTT LLP
STREET 2: 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR
CITY: MONTREAL
STATE: A8
ZIP: H3B 3V2
BUSINESS PHONE: 843-900-3201
MAIL ADDRESS:
STREET 1: C/O STIKEMAN ELLIOTT LLP
STREET 2: 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR
CITY: MONTREAL
STATE: A8
ZIP: H3B 3V2
FORMER COMPANY:
FORMER CONFORMED NAME: AETERNA LABORATORIES INC
DATE OF NAME CHANGE: 20000503
D
1
primary_doc.xml
X0708
D
LIVE
0001113423
Aeterna Zentaris Inc.
315 SIGMA DRIVE
SUMMERVILLE
SC
SOUTH CAROLINA
29486
843-900-3201
CANADA (FEDERAL LEVEL)
Aeterna Laboratories Inc.
AETERNA LABORATORIES INC
Corporation
true
Klaus
Paulini
Weismullerstrasse 50
Frankfurt
2M
GERMANY
60314
Executive Officer
Director
Leslie
Auld
315 Sigma Drive
Summerville
SC
SOUTH CAROLINA
29486
Executive Officer
Nicola
Ammer
Weismullerstrasse 50
Frankfurt
2M
GERMANY
60314
Executive Officer
Carolyn
Egbert
315 Sigma Drive
Summerville
SC
SOUTH CAROLINA
29486
Director
Robin
Smith Hoke
315 Sigma Drive
Summerville
SC
SOUTH CAROLINA
29486
Director
Gerard
Limoges
Weismullerstrasse 50
Frankfurt
2M
GERMANY
60314
Director
Brent
Norton
315 Sigma Drive
Summerville
SC
SOUTH CAROLINA
29486
Director
Gilles
Gagnon
315 Sigma Drive
Summerville
SC
SOUTH CAROLINA
29486
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2020-02-19
false
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 PARK AVENUE, 4TH FLOOR
NEW YORK
NY
NEW YORK
10022
IL
ILLINOIS
NY
NEW YORK
false
4500000
4500000
0
The issuer received gross proceeds of $4,500,000 from the issuance of 3,478,261 common shares in a registered directoffering and a concurrent private placement to purchase 0.75 common shares for each share purchased for cash in theoffering.
false
3
371250
0
The commissions were based on gross proceeds of the registered direct offering of common shares that was concurrentwith the private placement of unregistered warrants and includes a management fee.
0
false
Aeterna Zentaris Inc.
/s/ Klaus Paulini
Klaus Paulini
President and CEO
2020-02-28